Job Description
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
\n
\n
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
\n
The Opportunity:
\n
\n
This is a unique executive leadership opportunity to establish and lead Revolution Medicines' presence in Australia. Reporting to the Senior Vice President, JPAC, the Vice President & General Manager, Australia will build operations from the ground up while shaping the company's long-term commercial strategy in Australia.
\n
\n
As a member of the JPAC leadership team, this leader will be responsible for developing the Australian business strategy, establishing a high-performing organization, preparing the market for multiple oncology launches, and ensuring patients gain timely access to innovative therapies.
\n
\n
Initially, the role will focus on establishing the Australian affiliate and creating scalable operating infrastructure to support the company’s growth and future commercialization in Australia.
\n
\n
Success in the Role
\n
\n
Within the first 24–36 months, the successful leader will:
\n
\n
- \n
\nSuccessfully establish Revolution Medicines' Australian affiliate and operational infrastructure.
\n
\nBuild and lead a high-performing multifunctional leadership team.
\n
\nDevelop and execute launch readiness strategies for the company's oncology portfolio.
\n
\nPosition Australia as a strategic contributor to global clinical development.
\n
\nSecure optimal market access and reimbursement pathways for future products.
\n
\nEstablish strong partnerships with government agencies, key opinion leaders, patient organizations and healthcare institutions.
\n
\nBuild a culture that reflects Revolution Medicines' values of innovation, collaboration, integrity and patient focus.
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Key Responsibilities
\n
\n
Strategic & Business Leadership
\n
\n
- \n
\nServe as a core member of the JPAC Leadership Team, contributing to the global commercialization strategy and regional growth agenda.
\n
\nDevelop and execute the Australia business strategy aligned with global corporate objectives.
\n
\nBuild Revolution Medicines' long-term presence in Australia through sustainable commercial growth and organizational capability.
\n
\nLead strategic planning, portfolio prioritization and investment decisions for Australia.
\n
\nOwn the Australia P&L, ensuring disciplined financial management and effective resource allocation.
\n
\nIdentify emerging market opportunities, competitive dynamics and business risks while recommending appropriate strategic responses.
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Affiliate Build & Organizational Leadership
\n
\n
- \n
\nEstablish the Australian affiliate, including organizational design, governance, infrastructure and operational readiness.
\n
\nRecruit, develop and retain a high-performing cross-functional leadership team.
\n
\nFoster an inclusive, high-performance culture that reflects Revolution Medicines' mission and values.
\n
\nDevelop succession plans and leadership capability across the organization.
\n
\nPromote collaboration across regional and global matrix teams.
\n
\nLead organizational change while maintaining employee engagement during rapid business growth.
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Commercial Strategy & Launch Excellence
\n
\n
- \n
\nDevelop comprehensive pre-launch and commercialization strategies across the Revolution Medicines portfolio.
\n
\nLead launch planning across Medical Affairs, Commercial, Market Access, Regulatory and Operations.
\n
\nEnsure excellence in forecasting, portfolio planning, customer engagement and commercial execution.
\n
\nDrive data-informed decision making and leverage digital engagement capabilities to enhance customer experience.
\n
\n
\n
\n
\n
\n
\n
\n
Market Access & Government Affairs
\n
\n
- \n
\nDevelop integrated market access strategies that maximize patient access.
\n
\nLead engagement with the Therapeutic Goods Administration (TGA), Pharmaceutical Benefits Advisory Committee (PBAC), Medical Services Advisory Committee (MSAC), and other relevant regulatory and reimbursement bodies.
\n
\nBuild strong relationships with Federal, State and Territory governments, policymakers and industry associations.
\n
\nPartner with patient advocacy organizations and clinical societies to advance patient-centred healthcare policy.
\n
\nEnsure health economics, evidence generation and reimbursement planning are integrated into product development and launch strategies.
\n
\n
\n
\n
\n
\n
\n
\n
\n
Clinical Development & Medical Collaboration
\n
\n
- \n
\nPartner with Global Clinical Development and Medical Affairs to strengthen Australia's role in Revolution Medicines' global clinical programs.
\n
\nSupport investigator engagement, site selection and patient recruitment.
\n
\nBuild strategic relationships with leading oncology centres, cooperative clinical trial groups and academic institutions.
\n
\nEnsure commercial insights inform lifecycle planning and future development priorities.
\n
\n
\n
\n
\n
\n
\n
\n
Governance, Risk & Compliance
\n
\n
- \n
\nEnsure full compliance with all applicable regulatory, legal and corporate governance requirements.
\n
\nMaintain the highest standards of business integrity and ethical conduct.
\n
\nLead enterprise risk management, business continuity planning and operational resilience.
\n
\nOversee contracts, third-party relationships and local fiduciary responsibilities.
\n
\n
\n
\n
\n
\n
\n
\n
Required Skills, Experience and Education:
\n
\n
- \n
\nAdvanced degree in Life Sciences, Business Administration or a related discipline; MBA, PhD or PharmD preferred.
\n
\nSignificant senior leadership experience within the Australian biopharmaceutical industry.
\n
\nDemonstrated success leading commercial organizations and managing P&L accountability.
\n
\nExperience establishing, building or significantly scaling pharmaceutical affiliates.
\n
\nProven success leading oncology product launches, preferably within precision oncology.
\n
\nStrong understanding of the Australian pharmaceutical environment, including reimbursement, market access and healthcare policy.
\n
\nDemonstrated success influencing government stakeholders, regulators and external partners.
\n
\nExperience leading multifunctional, matrixed organizations in a global environment.
\n
\nStrong financial, strategic planning and organizational leadership capabilities.
\n
\nExceptional communication, stakeholder engagement and executive influencing skills.
\n
\nFluency in English is required.
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Preferred Skills:
\n
\n
- \n
\nPrecision oncology and biomarker-driven medicine.
\n
\nEarly commercial planning within clinical-stage biotechnology companies.
\n
\nExperience in high-growth or start-up biotechnology organizations.
\n
\nInternational leadership experience.
\n
\nProject and program management expertise.
\n
\n
\n
\n
\n
\n
\n
\n
\n
Leadership Competencies
\n
\n
The successful candidate will demonstrate:
\n
\n
- \n
\nStrategic and enterprise thinking.
\n
\nInspirational people leadership.
\n
\nEntrepreneurial mindset.
\n
\nCommercial acumen.
\n
\nPatient-first orientation.
\n
\nCourageous decision making.
\n
\nHigh integrity and accountability.
\n
\nStrong cross-functional collaboration.
\n
\nExecutive presence and influence.
\n
\nAbility to thrive in a dynamic, fast-paced growth environment.
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
Travel
\n
\n
- \n
- This role requires regular domestic travel across Australia and international travel to Revolution Medicines' global offices. \n
\n
\n
\n
\n
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and . For additional information, please contact .
\n
\n
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
\n
\n Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
\n
\n If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to so we can share these impersonations with our IT team for tracking and awareness.
\n